Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Honeywell and Wolters Kluwer team up to help employees safely return to the workplace
Honeywell and Wolters Kluwer today announced a collaboration to integrate Honeywell’s Industrial Internet of Things […]
Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems
Honeywell today announced it has agreed to acquire privately held Sparta Systems for $1.3 billion in […]
Angelini Pharma acquires Arvelle Therapeutics
Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini […]
Panxora leads $1.5m USD medical blockchain token fundraising
Panxora Digital Ventures, part of the Panxora Group announces it will lead token investment syndicate […]
Pill Connect secures £0.5m to take electronic smart pill bottle that monitors patient adherence to commercial launch
Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round with the […]
Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19
Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in […]
Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection
COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more